Schedule a meeting with our leadership team during the 43rd Annual J.P. Morgan Healthcare Conference.
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Meet with our team to:
Explore how our continuum of capabilities and expertise can help you meet your goals at any stage, from process development to commercial manufacturing.
Learn how we can help you streamline your path to market with our cutting-edge technology platforms.
Hear about our purpose-built, commercial cell and gene therapy facility in Hamilton, Canada, that features process and analytical development, training, QC and scalable manufacturing capabilities, offering you a seamless transition from clinical development to commercialization.
Our team looks forward to gathering with healthcare professionals and industry leaders to discover how we can work together to enable accessibility and affordability.
Have questions about our cell and gene therapy CDMO services? Contact us at cdmo@omniabio.com.
About OmniaBio
As a dedicated cell and gene therapy CDMO, OmniaBio's vision is to manufacture a disease-free future. Headquartered in Ontario, Canada, our core values of collaborative partnership converge with deep industry experience and innovation using the latest technologies to drive the future of cell and gene therapy manufacturing.